Pharmaceutical brands and media platforms, including connected TV (CTV), can activate HIPAA-compliant audiences built on real-world clinical and claims data through a new collaboration between PurpleLab® and Experian.
Targeting de-identified audiences is essential for engaging the right patients at pivotal moments in their health journey—maximizing ROI while safeguarding privacy and improving outcomes. Overall, prescription drugmakers spent $2.97 billion on national TV advertising in the first half of 2025, a 12.2% year-over-year increase, underscoring the growing demand for scalable, privacy-compliant healthcare advertising in premium media environments.
Now, whether you’re a pharma advertiser launching a new therapy or a platform curating health-focused inventory, PurpleLab’s integration refreshes the media planning ecosystem, offering marketers easier access to the audiences needed to drive impact.
Activate with Accuracy and Scale
PurpleLab’s de-identified healthcare segments, categorized by condition, treatment, specialty, and prescription behavior, are now accessible through the Experian Data Marketplace, streamlining media planning. This integration enables PurpleLab’s privacy-safe audiences to travel from discovery to omnichannel delivery. Experian then handles onboarding, activation, and audience expansion, in accordance with HIPAA and with industry standards.
Utilizing Experian’s identity graph, spanning household and individual-level insights, as well as marketing attributes, these healthcare audiences can be:
- Onboarded securely, matching hashed emails or tokens to digital identifiers
- Activated across major channels, including CTV, mobile, display, and social
- Expanded with confidence, reaching more of the target population, patients, or healthcare professionals, without relying on third-party cookies
This infrastructure unlocks greater scale and completeness for niche pharma audiences that have historically been hard to reach in digital and streaming environments. For brands navigating fragmented media and tightening privacy regulations, this collaboration provides the clarity and consistency they’ve been seeking.
“We know healthcare marketers are under pressure to get it right: to respect privacy, be accurate, and scale. That’s why we’re excited to bring PurpleLab audiences into the Experian data marketplace and make them available through Audigent’s curated deals,” said Kim Gilberti, GM of Experian Marketing Services. “ It gives pharmaceutical brands and platforms a clear way to plan and measure campaigns, with the assurance that they’re reaching patients and providers when it matters/in the right way.”
Curation Through Audigent: Premium Supply Meets Premium Data
For advertisers seeking turnkey media solutions, PurpleLab audiences are now also available through Audigent’s Curated Deals.
Audigent’s Curated Deals simplify media buying by packaging PurpleLab’s clinically grounded audiences with premium, brand-safe inventory, thus creating a unified package.
Instead of stitching together data and supply separately, media buyers can now access pre-built or custom-curated media deals where PurpleLab audiences are already integrated—ideal for health and wellness programming, premium CTV, or contextual content aligned to therapeutic areas. This approach gives marketers both efficiency and accuracy, streamlining execution while maintaining compliance and relevance.
“Bringing together PurpleLab’s clinically precise audiences with Experian’s powerful identity and activation capabilities—and pairing it with Audigent’s premium inventory—gives advertisers more than a turnkey solution. It’s the power to launch campaigns that truly resonate, with data and media working in harmony from day one to deliver both efficiency and impact,” says Scott Ronay, VP, Advertising Sales.
Real-world Use Cases: Accuracy with Purpose
CTV awareness for cardiovascular therapies
- A cardiovascular brand is launching a CTV campaign to reach healthcare providers involved in treatment decisions. Using PurpleLab’s provider-level segments from the Experian Data Marketplace, a brand can activate audiences across brand-safe, streaming environments. This strategy enables meaningful engagement with prescribers while maintaining scale and compliance across CTV and complementary digital channels.
Cross-device activation for high-impact health campaigns
- A biotech firm promoting a new therapy needs to reach patients who are likely to have a relevant condition, based on modeled audience segments. Using PurpleLab’s real-world patient segments, the advertiser activates across mobile, display, and CTV, with Experian’s identity graph ensuring household-level consistency across devices. Privacy and scale are preserved, while the brand ensures it’s not wasting impressions on ineligible or misaligned audiences.
Closed-Loop Measurement, Built for Healthcare
- Beyond targeting, the PurpleLab–Experian integration empowers advertisers to measure real-world outcomes, not just digital proxies. By leveraging tokenization, Experian enables ad exposure data to be securely matched back to de-identified health events within PurpleLab’s platform.
This means marketers can assess outcomes such as:
- Prescription lift among exposed vs. unexposed audiences
- HCP engagement and treatment initiation
- Patient adherence or follow-through behavior
This type of closed-loop reporting is critical in pharma, where traditional metrics like clicks or impressions don’t reflect business impact. Now, with token-based match-back, brands can see whether their campaigns are driving real results—securely and compliantly.
Ready to reach the right patients and providers—securely and at scale?
Explore PurpleLab audiences in the Experian Data Marketplace and Audigent Curated Deals to activate clinically grounded, privacy-compliant segments across CTV, display, mobile, and more.